Article
IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization
1 Feb 2023
Abstract excerpt
Type I interferons (IFN-Is) have been harnessed for cancer therapies due to their immunostimulatory functions. However, certain tumor-tolerating activities by IFN-Is also exist, and may potentially thwart their therapeutic effects. In this respect, our previous studies have demonstrated a monocyte-orchestrated, IFN-I-to-IL-4 cytokine axis, which can subsequently drive M2-skewed pro-tumoral polarization of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
